Natixis’s Opko Health OPK Stock Holding History

Natixis’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,000	Closed	-$67K	–	1284
2021 Q4	$67K	Buy	+14,000	New	+$56.7K	﹤0.01%	1196
2021 Q1	–	Sell	-13,000	Closed	-$51K	–	1155
2020 Q4	$51K	Buy	+13,000	New	+$54.3K	﹤0.01%	1023

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Natixis's OPK Position: Q1 2022 in Review

Natixis sold out of Opko Health (OPK) in Q1 2022, closing a stake of 14,000 shares — an estimated $67K sold.

Natixis first reported a position in OPK in Q4 2020 and held it in 2 quarters. The position peaked at $67K in Q4 2021. 229 funds tracked by Wall St. Rank hold OPK as of Q1 2022.

Natixis reported no remaining Opko Health position as of Q1 2022 after selling out during the quarter.
Natixis sold 14,000 Opko Health shares in Q1 2022, an estimated $67K.
Natixis first reported a position in Opko Health in Q4 2020 and held it in 2 quarters.
Natixis's Opko Health position peaked at $67K in Q4 2021.
229 funds tracked by Wall St. Rank held Opko Health as of Q1 2022.

Based on Natixis's 13F filing for Q1 2022, filed 13 May 2022.